BioMarin Pharmaceutical CEO: Substantial Profits Ahead | Mad Money | CNBC

BioMarin Pharmaceutical CEO: Substantial Profits Ahead | Mad Money | CNBC
BioMarin Pharmaceutical CEO Jean-Jacques Bienaimé chats with Jim Cramer about the impact of the recent FDA approval the company received for its hemophilia drug.
» Subscribe to CNBC: cnb.cx/Subscrib...
» Watch more Mad Money here: bit.ly/WatchMad...
» Read more about BioMarin Pharmaceutical: cnb.cx/2OjOPBm
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Get More Mad Money!
Read the latest news: madmoney.cnbc.com
Watch full episodes: bit.ly/MadMoney...
Follow Mad Money on Twitter: bit.ly/MadMoney...
Like Mad Money on Facebook: bit.ly/LikeMadM...
Follow Cramer on Twitter: bit.ly/FollowCr...
Connect with CNBC News Online!
Visit CNBC.com: www.cnbc.com/
Find CNBC News on Facebook: cnb.cx/LikeCNBC
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Google+: cnb.cx/PlusCNBC
Follow CNBC News on Instagram: cnb.cx/Instagra...
BioMarin Pharmaceutical CEO: Substantial Profits Ahead | Mad Money | CNBC